2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter SyndromeRichter transformationRecruitingPhase 22026-06-30NCT06186648
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settingschronic lymphocytic leukemia/small lymphocytic lymphomaActive, not recruitingNot stated2025-12-03NCT05590702